Screener/Healthcare/Biotechnology

NVAX

Novavax, Inc.NASDAQ
$9.34-0.39 (-3.96%)
Small CapUnder $10HealthcareFastest GrowingHigh BetaLow P/EUndervalued
$5.01
$11.97
$9.29
$9.72
EPS (TTM)$2.35
P/E Ratio3.97
Dividend Yield—
Market Cap$1.70B
Volume2.38M
Prev Close$9.72
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$147.1M$17.5M$0.0585.0%11.9%
Q3 '25$70.4M-$202.4M$-1.2569.5%-287.3%
Q2 '25$239.2M$106.5M$0.6293.6%44.5%
Q1 '25$666.7M$518.6M$2.9397.9%77.8%
Q4 '24$88.3M-$81.0M$-0.5258.5%-91.8%
Q3 '24$84.5M-$121.3M$-0.7628.3%-143.5%
Q2 '24$415.5M$162.4M$0.9988.9%39.1%
Q1 '24$93.9M-$147.6M$-1.0536.9%-157.2%
Get Your Daily Market Recap